Replaces Dirk Van Hyning, Who Resigned for Personal Reasons

Perth, Australia and Greer, South Carolina- 31 May 2018- Alexium International Group Limited (“Alexium,” “the Company”) (ASX: AJX, NASDAQ Designation: AXXIY) announces that Dr. Dirk Van Hyning has resigned from his position as Chief Executive Officer of the Company with effect from 31 May 2018, for personal reasons.The Board has appointed as Interim CEO, Dr. Robert (Bob) Brookins who is currently Alexium’s Executive Vice President of Research and Development and who has held operational roles with the company since 2010. As well as having been a major force in the development of the flame retardant technologies, Dr. Brookins has been the driver behind the evolution of Alexium’s bedding market technologies and in particular the phase change material (PCM) product line Alexicool®.

In this respect, Dr. Brookins has shown himself to be a commercially focused entrepreneur.

He has been working across the entire business and in particular has been:

  • orchestrating product development with end customers;
  • working closely with sales and marketing;
  • involved in all aspects of pricing, logistics and supply chain management; and
  • developing metrics to demonstrate the superior performance of Alexium’s products.

As such, over the past eight years, Dr. Brookins has developed from the research product developer to the innovator and joint market lead, and he has been instrumental in running the fast developing PCM part of the business from inception, development, and all the way to sales.

Dr. Brookins’ team of product development and research scientists has been instrumental to this effort. This team has been integral to Alexium’s growth and has facilitated Alexium’s business model of providing innovative products to address critical gaps in the flame retardant and PCM markets. Their support has enabled Dr. Brookins to take on expanded operational roles and drive a holistic vision for Alexium growth.

Alexium Board Chair Susan Thomas said, “We are grateful to Dirk for his five years of service to Alexium and wish him all the best going forward. I am delighted that Bob Brookins has agreed to serve as Interim CEO. Dr. Brookins has been with the Company since its inception. He is a very familiar face to our customers and partners, as well as the investment community. He has been instrumental in the development of Alexium’s market leading, proprietary technologies and shown that he has an ability to work closely with product development and marketing to bring innovative products to market.”

Dr. Brookins said, “Alexium has reached an exciting stage where the performance of our products is gaining wide market awareness which positions the Company to gain greater penetration into current markets and expansion into new. Coordination of Alexium resources to accomplish this is my focus, and I look forward to driving this effort.”

About Alexium International Group Limited

Alexium International Group Limited (ASX: AJX, Nasdaq Designation: AXXIY) holds proprietary patent applications for novel technologies developed to provide flame retardancy for a wide range of materials. These environmentally friendly flame retardants have applications for several industries and can be customized. Further, Alexium has developed products for a range of other applications including phase-change materials, water repellents, antimicrobials, and combinations thereof. Alexium also holds patents for a process developed initially by the U.S. Department of Defense, which allows for the surface modification and attachment of nanoparticles or multiple chemical functional groups to surfaces or substrates to provide functions such as fire retardancy, water proofing, oil proofing, and antimicrobial treatments. Applications under development include but are not limited to textiles, packaging, electronics, and building materials. Alexium’s chemical treatments are currently marketed as Alexicool® and Alexiflam®. For additional information about Alexium, please visit www.alexiuminternational.com.

US Contacts:
Bob Brookins
Interim CEO

Mark Wise
Vice President, Investor Relations